Clinical Trial Update: Semi-automatic Response System(SARS)in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial conducted by The Catholic University of Korea evaluating a Semi-automatic Response System (SARS) for Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: The Catholic University of Korea | Conditions: Diabetes Mellitus | NA | Status: COMPLETED